A new podcast, with a feminist host, aims to keep the decades-old diet brand in the GLP-1 conversation.
Category: Weight
-
In the Ozempic Era, Who Needs Weight Watchers?
The New York Times – Fashion & Style: -
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt
The New York Times – Business:People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adjust.
-
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
The New York Times – Business:Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.
-
Provincetown Bear Week Feels Different in the Age of GLP-1s
The New York Times – Fashion & Style:An annual celebration of bears — gay men on the bigger and hairier side — feels different in the age of GLP-1s.
-
Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know
The New York Times – Business:What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss.
-
How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company
The New York Times – Business:Who needs more than two employees when artificial intelligence can do so many corporate tasks? It’s super efficient — and a little bit lonely.
-
Ozempic Is About to Go Generic in India, China and Canada
The New York Times – Business:In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.